24860 Federal Register / Vol. 74, No. 99 / Tuesday, May 26, 2009 / Notices 

Dated: May 18, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. E9–12119 Filed 5–22–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control Initial Review Group, 

(NCIPC IRG) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) announce 

the following teleconference meetings: 

Times and Dates: 

12:30 p.m.–12:45 p.m., June 22, 2009 (Open). 

12:45 p.m.–7 p.m., June 22, 2009 (Closed). 

9 a.m.–9:15 a.m., June 23, 2009 (Open). 

9:15 a.m.–5 p.m., June 23, 2009 (Closed). 

9 a.m.–9:15 a.m., June 24, 2009 (Open). 

9:15 a.m.–5 p.m., June 24, 2009 (Closed). 

9 a.m.–9:15 a.m., June 25, 2009 (Open). 

9:15 a.m.–5 p.m., June 25, 2009 (Closed). 

Place: Teleconference, Toll Free: 877–468– 

4185, Participant Pass Code: 3772769. 

Status: Portions of the meeting will be 

closed to the public in accordance with 

provisions set forth in Section 552b(c)(4) and 

(6), Title 5, U.S.C., and the Determination of 

the Director, Management Analysis and 

Services Office, CDC, pursuant to Section 

10(d) of Public Law 92–463. 

Purpose: This group is charged with 

providing advice and guidance to the 

Secretary, Department of Health and Human 

Services, and the Director, CDC, concerning 

the scientific and technical merit of grant and 

cooperative agreement applications received 

from academic institutions and other public 

and private profit and nonprofit 

organizations, including State and local 

government agencies, to conduct specific 

injury research that focuses on prevention 

and control. 

Matters To Be Discussed: The meetings 

will include the review, discussion, and 

evaluation of applications submitted in 

response to Fiscal Year 2009 Requests for 

Applications related to the following 

individual research announcement: RFA– 

EH–09–001 Climate Change: Environmental 

Impact on Human Health (U01). 

Agenda items are subject to change as 

priorities dictate. 

CONTACT PERSON FOR MORE INFORMATION: 

Rick Waxweiler, Ph.D., Director, Extramural 

Research Program Office, National Center for 

Injury Prevention & Control and Executive 

Secretary, NCIPC IRG, CDC, 4770 Buford 

Highway, N.E., M/S F–62, Atlanta, Georgia 

30341, Telephone 770–488-4850. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 18, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–12120 Filed 5–22–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for the Accelerating 

Development of Methods for the Study 

of Complex Patients (R21) applications 

are to be reviewed and discussed at this 

meeting. These discussions are likely to 

reveal personal information concerning 

individuals associated with the 

applications. This information is 

exempt from mandatory disclosure 

under the above-cited statutes. 

SEP Meeting on: Accelerating Development 

of Methods for the Study of Complex Patients 

(R21). 

Date: June 23, 2009 (Open on June 23 from 

1 p.m. to 1:15 p.m. and closed for the 

remainder of the meeting). 

Place: Agency for Healthcare Research and 

Quality, John Eisenberg Building, Conference 

Center, Rockville, Maryland 20850. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

Dated: May 15, 2009. 

Carolyn M. Clancy, 

Director. 

[FR Doc. E9–12068 Filed 5–22–09; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Pediatric Functional 

Neuroimaging Research Network. 

Date: June 26, 2009. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Sathasiva B. Kandasamy, 

PhD, Scientific Review Administrator, 

Division of Scientific Review, National 

Institute of Child Health and Human 

Development, 6100 Executive Boulevard, 

Room 5B01, Bethesda, MD 20892–9304, (301) 

435–6680, skandasa@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS)